HIV Vaccines

Collaboration Will Work on Vaccine

Published in AIDS Weekly, March 6th, 2000

Targeted Genetics Corp. is collaborating with two institutions to develop a vaccine to prevent AIDS, the three concerns said in a joint statement on February 16, 2000.

Seattle, Washington-based Targeted Genetics will make the vaccine by using its viral vector technology to deliver HIV genes into humans with the goal of creating a protective immune response.

Under the terms of the collaboration, the International AIDS Vaccine Initiative (IAVI) will fund development, preclinical, and Phase I studies of the vaccine at Targeted Genetics and at Columbus, Ohio-based Children's Research Institute, the statement said.

In June 1999,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2000-03-06)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry